Psoriasis (Auckland, N.Z.)

Keyphrases

Publications

volume 14, 2024

David Singer, Philippe Thompson-Leduc, Siyu Ma, Deepshekhar Gupta, Wendy Y Cheng, Selvam R Sendhil, Manasvi Sundar, Ella Hagopian, Nikita Stempniewicz, Mei Sheng Duh, Sara Poston
Burden of Herpes Zoster Among Patients with Psoriatic Arthritis in the United States. Psoriasis (Auckland, N.Z.) 14 (2024)
Mohammad I Fatani, Ibrahim Abdulrazag Al-Homood, Mohammed K Bedaiwi, Sahar Al Natour, Alper Erdogan, Aya Alsharafi, Suzan Mansour Attar
Experiences of Dermatologists and Patients Regarding Psoriasis and Its Connection to Psoriatic Arthritis in Saudi Arabia. Psoriasis (Auckland, N.Z.) 14 (2024)
David Singer, Philippe Thompson-Leduc, Siyu Ma, Deepshekhar Gupta, Wendy Y Cheng, Selvam R Sendhil, Manasvi Sundar, Ella Hagopian, Nikita Stempniewicz, Mei Sheng Duh, Sara Poston
Burden of Herpes Zoster Among Patients with Psoriatic Arthritis in the United States. Psoriasis (Auckland, N.Z.) 14 (2024)
Stefana Bucur, Elena-Daniela Serban, Bogdan Vasile Ileanu, Raluca Simona Costache, Alin Codrut Nicolescu, Traian Constantin, Daniel Octavian Costache, Maria-Magdalena Constantin
Effectiveness and Drug Survival of Ixekizumab and Secukinumab in Patients with Moderate to Severe Plaque Psoriasis: Real-World Data from Bucharest, Romania. Psoriasis (Auckland, N.Z.) 14 (2024)
Federica Rega, Federica Trovato, Giulio Bortone, Giovanni Pellacani, Antonio Giovanni Richetta, Annunziata Dattola
Therapeutic Potential of Spesolimab-Sbzo in the Management of Generalized Pustular Psoriasis Flares in Adults: Evidence to Date. Psoriasis (Auckland, N.Z.) 14 (2024)
María José Valencia López, Brigitte Stephan, Anna Meineke, Sandra Wolf, Diamant Thaҫi, Ulrich Mrowietz, Valerie Andrees, Stephan Jeff Rustenbach, Kristian Reich, Linus Thalmann, Henriette Bogena, Petra Staubach-Renz, Ralph Michael von Kiedrowski, Matthias Augustin
Perception and Impact of COVID-19 Pandemic in Psoriasis Patients: Data from the German PsoBest and the CoronaBest Registries. Psoriasis (Auckland, N.Z.) 14 (2024)
Stefana Bucur, Elena-Daniela Serban, Bogdan Vasile Ileanu, Raluca Simona Costache, Alin Codrut Nicolescu, Traian Constantin, Daniel Octavian Costache, Maria-Magdalena Constantin
Effectiveness and Drug Survival of Ixekizumab and Secukinumab in Patients with Moderate to Severe Plaque Psoriasis: Real-World Data from Bucharest, Romania. Psoriasis (Auckland, N.Z.) 14 (2024)
Luca Potestio, Giuseppe Lauletta, Nello Tommasino, Antonio Portarapillo, Antonia Salsano, Teresa Battista, Fabrizio Martora, Matteo Megna
Risk Factors for Psoriasis Flares: A Narrative Review. Psoriasis (Auckland, N.Z.) 14 (2024)
Ana Maria Alexandra Stanescu, Gabriel Cristian Bejan, Mihaela Daniela Balta, Octavian Andronic, Cristian Toma, Stefan Busnatu
The Perspective of Cannabidiol in Psoriasis Therapy. Psoriasis (Auckland, N.Z.) 14 (2024)
Luca Potestio, Giuseppe Lauletta, Nello Tommasino, Antonio Portarapillo, Antonia Salsano, Teresa Battista, Fabrizio Martora, Matteo Megna
Risk Factors for Psoriasis Flares: A Narrative Review. Psoriasis (Auckland, N.Z.) 14 (2024)
Federica Rega, Federica Trovato, Giulio Bortone, Giovanni Pellacani, Antonio Giovanni Richetta, Annunziata Dattola
Therapeutic Potential of Spesolimab-Sbzo in the Management of Generalized Pustular Psoriasis Flares in Adults: Evidence to Date. Psoriasis (Auckland, N.Z.) 14 (2024)
Mohammad I Fatani, Ibrahim Abdulrazag Al-Homood, Mohammed K Bedaiwi, Sahar Al Natour, Alper Erdogan, Aya Alsharafi, Suzan Mansour Attar
Experiences of Dermatologists and Patients Regarding Psoriasis and Its Connection to Psoriatic Arthritis in Saudi Arabia. Psoriasis (Auckland, N.Z.) 14 (2024)
Kathryn Haran, Allison Kranyak, Chandler E Johnson, Payton Smith, Aaron S Farberg, Tina Bhutani, Wilson Liao
Commercial Diagnostics and Emerging Precision Medicine Technologies in Psoriasis and Atopic Dermatitis. Psoriasis (Auckland, N.Z.) 14 (2024)
Payton Smith, Allison Kranyak, Chandler E Johnson, Kathryn Haran, Isabel Muraguri Snr, Toby Maurer, Tina Bhutani, Wilson Liao, Samson Kiprono
Adapting the Goeckerman Regimen for Psoriasis Treatment in Kenya: A Case Study of Successful Management in a Resource-Limited Setting. Psoriasis (Auckland, N.Z.) 14 (2024)
Alim Osman, Alexandra Nigro, Amanda Chen Taylor, Ryan Saal, Ana Ormaza Vera, Clinton Enos
The Effects of Cardiometabolic Comorbidities on Biologic Treatment for Psoriasis with Respect to PASI Scores: A Qualitative Systematic Review. Psoriasis (Auckland, N.Z.) 14 (2024)
Ana Maria Alexandra Stanescu, Gabriel Cristian Bejan, Mihaela Daniela Balta, Octavian Andronic, Cristian Toma, Stefan Busnatu
The Perspective of Cannabidiol in Psoriasis Therapy. Psoriasis (Auckland, N.Z.) 14 (2024)
Alim Osman, Alexandra Nigro, Amanda Chen Taylor, Ryan Saal, Ana Ormaza Vera, Clinton Enos
The Effects of Cardiometabolic Comorbidities on Biologic Treatment for Psoriasis with Respect to PASI Scores: A Qualitative Systematic Review. Psoriasis (Auckland, N.Z.) 14 (2024)
Kathryn Haran, Allison Kranyak, Chandler E Johnson, Payton Smith, Aaron S Farberg, Tina Bhutani, Wilson Liao
Commercial Diagnostics and Emerging Precision Medicine Technologies in Psoriasis and Atopic Dermatitis. Psoriasis (Auckland, N.Z.) 14 (2024)
Somina Shaikh
NSAIDs: Unveiling Their Role in Drug-Induced Psoriasis [Letter]. Psoriasis (Auckland, N.Z.) 14 (2024)
María José Valencia López, Brigitte Stephan, Anna Meineke, Sandra Wolf, Diamant Thaҫi, Ulrich Mrowietz, Valerie Andrees, Stephan Jeff Rustenbach, Kristian Reich, Linus Thalmann, Henriette Bogena, Petra Staubach-Renz, Ralph Michael von Kiedrowski, Matthias Augustin
Perception and Impact of COVID-19 Pandemic in Psoriasis Patients: Data from the German PsoBest and the CoronaBest Registries. Psoriasis (Auckland, N.Z.) 14 (2024)

volume 13, 2023

Valentina Perrone, Serena Losi, Silvia Sabatino, Maurizio Mezzetti, Melania Dovizio, Diego Sangiorgi, Luca Degli Esposti
Analysis of Drug Utilization in Patients with Psoriasis: A Real-World Retrospective Study Among the Italian Population. Psoriasis (Auckland, N.Z.) 13 (2023)
Luca Potestio, Fabrizio Martora, Gabriella Fabbrocini, Teresa Battista, Matteo Megna
Safety and Efficacy of Covid-19 Vaccination in Patients Undergoing Biological Treatments for Psoriasis. Psoriasis (Auckland, N.Z.) 13 (2023)
Valentina Perrone, Serena Losi, Silvia Sabatino, Maurizio Mezzetti, Melania Dovizio, Diego Sangiorgi, Luca Degli Esposti
Analysis of Drug Utilization in Patients with Psoriasis: A Real-World Retrospective Study Among the Italian Population. Psoriasis (Auckland, N.Z.) 13 (2023)
Riley K Spencer, Joy Q Jin, Kareem G Elhage, Mitchell S Davis, Wilson Liao, Tina Bhutani
Management of Plaque Psoriasis in Adults: Clinical Utility of Tapinarof Cream. Psoriasis (Auckland, N.Z.) 13 (2023)
Valentina Celoria, Francois Rosset, Valentina Pala, Paolo Dapavo, Simone Ribero, Pietro Quaglino, Luca Mastorino
The Skin Microbiome and Its Role in Psoriasis: A Review. Psoriasis (Auckland, N.Z.) 13 (2023)
Luca Potestio, Angelo Ruggiero, Gabriella Fabbrocini, Fabrizio Martora, Matteo Megna
Effectiveness and Safety of Deucravacitinib for the Management of Psoriasis: A Review of the Current Literature. Psoriasis (Auckland, N.Z.) 13 (2023)
Luca Potestio, Angelo Ruggiero, Gabriella Fabbrocini, Fabrizio Martora, Matteo Megna
Effectiveness and Safety of Deucravacitinib for the Management of Psoriasis: A Review of the Current Literature. Psoriasis (Auckland, N.Z.) 13 (2023)
Luca Potestio, Angelo Ruggiero, Gabriella Fabbrocini, Fabrizio Martora, Matteo Megna
Effectiveness and Safety of Deucravacitinib for the Management of Psoriasis: A Review of the Current Literature. Psoriasis (Auckland, N.Z.) 13 (2023)
Vito Di Lernia, Francesca Peccerillo, Elena Ficarelli
Therapeutic Management of a Case of Severe Psoriasis Coexistent with Bullous Pemphigoid in the Elderly. Psoriasis (Auckland, N.Z.) 13 (2023)
Kristine Heidemeyer, Marco May Lee, Simone Cazzaniga, Nikhil Yawalkar, Luigi Naldi
Palmoplantar Pustulosis: A Systematic Review of Risk Factors and Therapies. Psoriasis (Auckland, N.Z.) 13 (2023)

volume 12, 2022

Ranju Pokharel, Sudha Agrawal, Prajwal Pandey, Madhab Lamsal
Assessment of Vitamin D Level in Patients with Psoriasis and Its Correlation with Disease Severity: A Case-Control Study. Psoriasis (Auckland, N.Z.) 12 (2022)
Mimi Chung, Erin Bartholomew, Samuel Yeroushalmi, Marwa Hakimi, Tina Bhutani, Wilson Liao
Dietary Intervention and Supplements in the Management of Psoriasis: Current Perspectives. Psoriasis (Auckland, N.Z.) 12 (2022)
Paolo Gisondi, Francesco Bellinato, Martina Maurelli, Davide Geat, Alen Zabotti, Dennis McGonagle, Giampiero Girolomoni
Reducing the Risk of Developing Psoriatic Arthritis in Patients with Psoriasis. Psoriasis (Auckland, N.Z.) 12 (2022)
Elisa Camela, Luca Potestio, Ruggiero Angelo, Sonia Sofia Ocampo-Garza, Gabriella Fabbrocini, Matteo Megna
Towards Personalized Medicine in Psoriasis: Current Progress. Psoriasis (Auckland, N.Z.) 12 (2022)
Ruggiero Angelo, Luca Potestio, Elisa Camela, Gabriella Fabbrocini, Matteo Megna
Bimekizumab for the Treatment of Psoriasis: A Review of the Current Knowledge. Psoriasis (Auckland, N.Z.) 12 (2022)
Eveline De Brandt, Tom M Hillary
Comorbid Psoriasis and Metabolic Syndrome: Clinical Implications and Optimal Management. Psoriasis (Auckland, N.Z.) 12 (2022)
Murlidhar Rajagopalan, Sunil Dogra, Kiran Godse, Bikash Ranjan Kar, Sai Krishna Kotla, Shekhar Neema, Abir Saraswat, Swapnil Deepak Shah, Nina Madnani, Vidyadhar Sardesai, Rajiv Sekhri, Sachin Varma, Sandeep Arora, Pallavi Kawatra
Therapeutic Inertia in the Management of Psoriasis: A Quantitative Survey Among Indian Dermatologists and Patients. Psoriasis (Auckland, N.Z.) 12 (2022)
Pau Rosés Gibert, Francisco Javier de la Torre Gomar, Amaia Saenz Aguirre, Javier Gimeno Castillo, Ricardo González Pérez
Dimethyl Fumarate as Therapeutic Alternative in Moderate-to-Severe Psoriasis: Our Experience. Psoriasis (Auckland, N.Z.) 12 (2022)
Christine Daugaard, Lars Iversen, Kasper Fjellhaugen Hjuler
Comorbidity in Adult Psoriasis: Considerations for the Clinician. Psoriasis (Auckland, N.Z.) 12 (2022)
Matteo Megna, Luca Potestio, Gabriella Fabbrocini, Ruggiero Angelo
Long-Term Efficacy and Safety of Guselkumab for Moderate to Severe Psoriasis: A 3-Year Real-Life Retrospective Study. Psoriasis (Auckland, N.Z.) 12 (2022)
Chanel Claudine de Ruiter, Thomas Rustemeyer
Biologics Can Significantly Improve Dermatology Life Quality Index (DLQI) in Psoriatic Patients: A Systematic Review. Psoriasis (Auckland, N.Z.) 12 (2022)
Alison Havelin, Philip J Hampton
Telemedicine and e-Health in the Management of Psoriasis: Improving Patient Outcomes - A Narrative Review. Psoriasis (Auckland, N.Z.) 12 (2022)
Zoe Diana Draelos
The Efficacy and Tolerability of Turmeric and Salicylic Acid in Psoriasis Treatment. Psoriasis (Auckland, N.Z.) 12 (2022)
Samuel Yeroushalmi, Marwa Hakimi, Mimi Chung, Erin Bartholomew, Tina Bhutani, Wilson Liao
Psoriasis and Exercise: A Review. Psoriasis (Auckland, N.Z.) 12 (2022)
Vishalakshi Viswanath, Pradnya Joshi, Prakash Lawate, Dakshata Tare, Dhiraj Dhoot, Namrata Mahadkar, Hanmant Barkate
An Open-Label, Randomized, Prospective, Comparative, Three-Arm Clinical Trial to Evaluate the Safety and Effectiveness of Apremilast with Three Different Titration Methods in Patients with Chronic Plaque Psoriasis in India. Psoriasis (Auckland, N.Z.) 12 (2022)
Maartje R van Acht, Juul M P A van den Reek, Elke M G J de Jong, Marieke M B Seyger
The Effect of Lifestyle Changes on Disease Severity and Quality of Life in Patients with Plaque Psoriasis: A Narrative Review. Psoriasis (Auckland, N.Z.) 12 (2022)
Laura I Ortiz-Lopez, Vivek Choudhary, Wendy B Bollag
Updated Perspectives on Keratinocytes and Psoriasis: Keratinocytes are More Than Innocent Bystanders. Psoriasis (Auckland, N.Z.) 12 (2022)
Sofia Löfvendahl, Jenny M Norlin, Marcus Schmitt-Egenolf
Economic Burden of Generalized Pustular Psoriasis in Sweden: A Population-Based Register Study. Psoriasis (Auckland, N.Z.) 12 (2022)
A Al-Janabi, Z Z N Yiu
Biologics in Psoriasis: Updated Perspectives on Long-Term Safety and Risk Management. Psoriasis (Auckland, N.Z.) 12 (2022)
Matteo Megna, Luigi Fornaro, Luca Potestio, Maria Antonietta Luciano, Mariateresa Nocerino, Mario Delfino, Maria Guarino, Gabriella Fabbrocini, Elisa Camela
Efficacy and Safety of Anti-TNF Biosimilars for Psoriasis in Pediatric and Geriatric Populations: A 72-Week Real-Life Study. Psoriasis (Auckland, N.Z.) 12 (2022)